...
首页> 外文期刊>Human Pathology >Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters
【24h】

Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters

机译:IV阶段结直肠癌患者肝脏转移中的组织病理学变量:差异簇潜在的预后相关性

获取原文
获取原文并翻译 | 示例

摘要

The prognosis of patients with colorectal liver metastases (LMs) is mostly established on clinical variables or on the anatomic extent of colorectal cancer (CRC). Histopathological factors of LMs which may actually reflect the biological aggressiveness of the tumor are not routinely considered to define the risk of worse clinical outcome in those patients. The number of poorly differentiated clusters (PDCs) of neoplastic cells in primary CRC is associated with metastatic risk and bad prognosis, but PDC presence in LMs has been barely analyzed thus far. We assessed PDC presence in the histological slides of surgically resected and synchronous LMs in 63 patients with CRC who had been not submitted to any neoadjuvant treatments. Then, we analyzed its association with patients’ cancer-specific survival (CSS) or progression-free survival. The presence of PDCs (P =.016) and PDC localization at tumor edge of LMs (P =.0004) were significantly associated with shorter CSS. PDC presence at the periphery of LMs and positive resection margin were independent prognostic variables for CSS. PDC localization at the tumor edge of LMs was a significant (P =.0079) and independent prognosticator of shorter progression-free survival. Our data suggest that PDC presence and peripheral localization in LMs may be relevant to predict outcome and useful for clinical decision making in patients with colorectal synchronous LMs.
机译:结直肠肝转移患者(LMS)的预后主要是在临床变量或结直肠癌(CRC)的解剖程度上建立。 LMS的组织病理因素实际上可能反映肿瘤的生物侵袭性未经常考虑定义这些患者临床结果的风险。初级CRC中肿瘤细胞的较差簇(PDC)的数量与转移性风险和预后不良相关,但到目前为止,LMS中的PDC存在已经几乎分析。我们评估了在未提交任何Neoadjuvant治疗的CRC患者的手术切除和同步LMS的组织学幻灯片中的PDC存在。然后,我们分析了与患者的癌症特异性生存(CSS)或无进展生存的关联。 LMS肿瘤边缘的PDC(P =,016)和PDC定位的存在显着与较短的CSS显着相关。 LMS周边和阳性切除边缘周边的PDC存在是CSS的独立预后变量。 LMS肿瘤边缘的PDC定位是显着的(P = .0079)和无级进展存活的独立预测器。我们的数据表明,LMS中的PDC存在和外围定位可能与预测结果有关,可用于结直肠同步LMS患者的临床决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号